Print

Reagent Proteins Establishes Exclusive Distribution Agreement in Japan with Funakoshi Co.  
8/3/2011 10:48:13 AM

San Diego, CA & Tokyo, Japan August 3, 2011 – Pfenex Inc. and Funakoshi Co., Ltd. today announced that they have entered into a distribution agreement. Under the terms of the agreement, Pfenex has appointed Funakoshi as the exclusive distributor for the entire Reagent Proteins catalogue in Japan. The Reagent Proteins catalogue contains over 2,300 products and spans a diverse range of reagent, pre-clinical and cGMP grade proteins focused on meeting the needs of the biopharmaceutical, infectious disease research and vaccine development communities.

“We are pleased to establish this distribution relationship with Funakoshi." stated Patrick K. Lucy, Vice President, Business Development at Pfenex Inc., “This agreement represents another significant milestone in the growth of our Reagent Proteins business unit by enabling us to establish an international presence and access the Japanese research market. We welcome the opportunity to work with a world class distributor such as Funakoshi to enable placing high quality reagent proteins in the hands of life science researchers. We are very impressed with Funakoshi’s reputation, capabilities and deep insight into the Japanese research reagent market and look forward to growing this relationship.”

“We are delighted with the Pfenex distribution agreement, which offers proteins produced by the proprietary Pfenex Expression Technology utilizing Pseudomonas fluorescens and other production hosts. Reagent Proteins perfectly complements our portfolio range of high quality products and services. Reagent Proteins recombinant proteins expressed from Pseudomonas fluorescens provides Funakoshi Company the opportunity to meet high demands for basic bioscience research and a source for the development of pharmaceutical proteins in Japan.” said Dr. Ryoya Funakoshi, President & CEO of Funakoshi Company, Ltd.

About Reagent Proteins

Reagent Proteins is a leading supplier of reagent, pre-clinical and cGMP grade proteins to the biopharmaceutical and vaccine development community. We ensure that scientists have ready access to a comprehensive offering of high quality proteins to enable their development efforts to proceed efficiently. For more information please visit www.reagentproteins.com

About Pfenex Inc.

Pfenex Inc. is a protein production company leveraging the unique and powerful Pfenex Expression Technology™ platform based on the micro-organism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information please visit www.pfenex.com

About FUNAKOSHI

Funakoshi Co., Ltd. has contributed as a leader to distribute research reagents and instruments for researchers in life science fields since its foundation. The mission of Funakoshi is offering many useful tools with leading edge technologies for Japanese researchers from all over the world to support and develop their research. For more information, visit Funakoshi's website: www.funakoshi.co.jp.

Pfenex Contact:

Cassidy Brady

Marketing Manager

858-352-4322 / cbrady@pfenex.com

Funakoshi Contact:

Takashi Saito

Operating Officer

+81-3-5684-1611/ saito-takashi@funakoshi.co.jp


//-->